23 Jun 2008 14:44
Immediate Release: Monday 23 June 2008
PLETHORA SOLUTIONS HOLDINGS PLC
("Plethora" or "the Company")
Plethora Solutions Holdings PLC (AIM : PLE), the developer of products for the treatment of urological disorders, held its Annual General Meeting today, June 23rd 2008, where all resolutions were duly passed.
AGM Statement
The Company has achieved significant commercial and development milestones during 2007 and continues to make good progress during 2008 in both the male and female health portfolios.
Plethora's US subsidiary, Timm Medical, continues to achieve sales growth in line with expectations and, with a strengthened balance sheet, the Company believes it is approaching a definitive convergence of its development and commercial activities which puts it in a very strong position to deliver a profitable, cash generative, speciality healthcare business.
-Ends-
For further information contact:
| Plethora Solutions Steven Powell | Tel : 020 3077 5406 |
| Hansard Group Adam Reynolds/John Bick | Tel: 020 7245 1100 |
About Plethora:
Plethora is focused on the development and marketing of products for the treatment of urological disorders. The Company has products in clinical development for the treatment of overactive bladder, stress urinary incontinence, interstitial cystitis, gynaecological pain, erectile dysfunction and premature ejaculation. Plethora has a US subsidiary, Timm Medical Technologies Inc, which markets products for the treatment of erectile dysfunction (ED) to urology clinics through a national US specialty sales team. The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE). Further information is available at www.plethorasolutions.co.uk.
Plethora Solutions Holdings Plc (PLE)